CHOSEN DIAGNOSTICS INC

HOME | CHOSEN DIAGNOSTICS

New Orleans, United States · Founded 2019 · $2.1M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$2.1M
Last Round
$2.1M GrantJan 2021
Rounds
2

About

Chosen Diagnostics is an award-winning, female-owned small business developing noninvasive diagnostic biomarker tests for life-threatening neonatal diseases. Its lead product, NECDetect, uses a stool-based biomarker panel to diagnose necrotizing enterocolitis in preterm infants with 93% sensitivity. The company holds FDA Breakthrough Device designation and has received over $4M in NIH and NSF SBIR grants.

Summary

CHOSEN DIAGNOSTICS INC is a Biotech company based in New Orleans, United States, founded in 2019. It has raised $2.1M in total across 2 rounds, most recently a $2.1M Grant round in Jan 2021. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2021
$2.1M

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CHOSEN DIAGNOSTICS INC on Indexed.vc
<a href="https://indexed.vc/companies/chosen-diagnostics-inc"><img src="https://indexed.vc/api/badge/company/chosen-diagnostics-inc" alt="CHOSEN DIAGNOSTICS INC on Indexed.vc" width="260" height="76" /></a>